Howard Wooding Rogers, M.D.-Ph.D.
`
`HOME ADDRESS
`54 Hilltop Drive
`Madison, CT 06443
`Email: rogershoward@sbcglobal.net
`Practice Website: advanceddermatologyct.com
`
` Tel: (860)859-2262
`Fax: (860)859-9819
`Cell: (860)917-8842
`
`MEDICAL EXPERIENCE
`Guilford, CT
`2017-Pres. Shoreline Mohs Surgery
`Private Practice Dermatologic Surgery (Owner)
`
`Norwich, CT
`2004-Pres. Advanced Dermatology LLC
`Private Practice General and Surgical Dermatology (Owner)
`
`Norwich, CT
`2000-2004 Chelsea Clinic Surgery
`Private Practice General and Dermatologic Surgery
`
`EDUCATION
`Cincinnati, OH
`2007-2008 Skin Cancer Center
`Surgical Fellowship in Mohs Micrographic Surgery
`
`1997-2000 Washington University School of Medicine St. Louis, MO
`Dermatology Residency, Chief Resident
`
`1996-1997 University of Maryland Hospital
`Internship in Internal Medicine
`
`Baltimore, MD
`
`1989-1996 Washington University School of Medicine St. Louis, MO
`M.D.-Ph.D. Combined Degree Program
`Ph.D. in Immunology
`
`1
`
`
`
`HOME ADDRESS
`54 Hilltop Drive
`Madison, CT 06443
`Email: rogershoward@sbcglobal.net
`Practice Website: advanceddermatologyct.com
`
` Tel: (860)859-2262
`Fax: (860)859-9819
`Cell: (860)917-8842
`
`MEDICAL EXPERIENCE
`Guilford, CT
`2017-Pres. Shoreline Mohs Surgery
`Private Practice Dermatologic Surgery (Owner)
`
`Norwich, CT
`2004-Pres. Advanced Dermatology LLC
`Private Practice General and Surgical Dermatology (Owner)
`
`Norwich, CT
`2000-2004 Chelsea Clinic Surgery
`Private Practice General and Dermatologic Surgery
`
`EDUCATION
`Cincinnati, OH
`2007-2008 Skin Cancer Center
`Surgical Fellowship in Mohs Micrographic Surgery
`
`1997-2000 Washington University School of Medicine St. Louis, MO
`Dermatology Residency, Chief Resident
`
`1996-1997 University of Maryland Hospital
`Internship in Internal Medicine
`
`Baltimore, MD
`
`1989-1996 Washington University School of Medicine St. Louis, MO
`M.D.-Ph.D. Combined Degree Program
`Ph.D. in Immunology
`
`1
`
`
`
`1985-1989 Harvard University
`B.S. in Biology, Magna Cum Laude
`
`Cambridge, MA
`
`CERTIFICATIONS
`2000, 2010 Board Certified American Board of Dermatology
`2009
`Fellow member American College of Mohs Micrographic
`Surgery
`
`MEDICAL ASSOCIATIONS AND POSITIONS
`Fellow member American Academy of Dermatology, Fellow member
`American College of Mohs Surgery, American Society of Mohs Surgery,
`American Society of Dermatologic Surgery, Masters Dermatologic
`Association, American Medical Association, Connecticut Dermatology
`Society, American Dermatologic Association
`
`NATIONAL ASSOCIATION LEADERSHIP
`American Academy of Dermatology
`-Chair, Patient Access and Payer Relations Committee 2014-2018, advisor
`2018-present
`-Chair, Physician Payment Reform Workgroup 2011-2012
`-Board of Directors, SkinPAC Political Action Committee 2018-present
`-Coding and Reimbursement Committee 2019-present
`-Performance Measures Committee 2013-2018
`-Healthcare Finance Committee 2011-2014
`-Workgroup on Innovation in Payment and Delivery 2013-present, chair
`2020-present
`-Expert Resource Group of Quality and Patient Safety 2013-2016
`
`2
`
`
`
`-Private Sector Advocacy Taskforce 2012-2014
`-Deputy Chair, Resource Based Relative Value System Committee 2015-
`present
`-Chair, Phototherapy Documentation Workgroup 2016-2017
`-Skin Cancer Measure Development Workgroup 2014-2016
`-Patient Reported Outcomes Measure Development Workgroup 2016-2018
`-Governmental Affairs and Healthcare Policy Council 2017-2019
`-Performance Measures Needs Assessment Workgroup 2017-2018
`-Immunohistochemistry Appropriate Use Workgroup 2019
`-Evaluation and Management Member Education Workgroup 2020-present
`-Question of the Week Coding Workgroup 2019-2020
`-Connecticut State Leader Legislative Conference 2020
`-Step Therapy Workgroup 2020
`-Task Force on E/M Coding Revision Impact 2021
`American College of Mohs Surgery
`-Vice President 2021
`-Secretary Treasurer 2020-2021
`-ACMS Board of Directors 2016-2019
`-Chair, AMCS Private Sector Task Force 2013-pres
`- Scientific Program Committee Cochair 2012, Chair 2013, Ex Officio 2014,
`Member 2020-present
`- ACMS representative to AMA Relative Value Update Committee (RUC)
`2014 –pres
`-Chair, ACMS Finance Committee 2020-2021
`- ACMS National Registry and Outcomes Committee, Vice Chair 2013-
`2016, Chair 2017-2019, advisor 2020-present
`- Chair of ACMS Mohs Log Subcommittee 2013-2015
`
`3
`
`
`
`-ACMS representative to Centers for Medicare and Medicaid Services
`MACRA Resource Use Measure Clinical Committee 2016- 2020
`
`-Chair of Oncology Subcommittee of Centers for Medicare and Medicaid
`Services Acumen MACRA Resource Use Measure Clinical Committee 2018
`-Chair of Dermatologic Care Subcommittee of Centers for Medicare and
`Medicaid Services Acumen MACRA Resource Use Measure Clinical
`Committee 2019-2021
`-Public Policy Committee 2012-pres
`-Alliance for Specialty Medicine (ASM), ACMS Representative 2014-pres
`- ACMS Membership Committee 2012-2014, 2020-2021
`American Society of Dermatologic Surgery
`-ASDS State Advocacy Taskforce 2020
`-ASDS Task Force on Value Analysis 2016-pres
`-ASDS Alternative Payment Model Workgroup 2014—2015
`Centers for Medicare and Medicaid Services
`Dermatology representative to Carrier Advisory Committee for Medicare
`Administrative Contractor, National Government Services 2019-present
`
`Council of Medical Specialty Societies
`-Representative to the Ambulatory Quality Alliance 2012-2013
`Congressional Testimony
`-Testified before Congressional Small Business Committee representing
`AADA regarding the burden of step therapy and prior authorization 2019
`
`INDUSTRY POSITIONS
`-Humana Inc., Physician Provider Collaborative Committee, 2013-2016
`-Case and policy reviewer for Medical Review Institute of America
`
`4
`
`
`
`COMMUNITY SERVICE
`2000-pres. Organized 53 community skin cancer screening programs in
` conjunction with William W. Backus Hospital
`2002-pres. Speaker for community education program in conjunction with
`William W. Backus Hospital education department
`
`CLINICAL RESEARCH
`2001-2003 Phase 3 study site for efalizumab efficacy in psoriasis
`(Genentech)
`2005 Trial study site for community based efficacy study of
`adapalene for acne (Galderma)
`2005-2008. ATLAS study on long term safety of alefacept for psoriasis
`(Biogen-Idec)
`
`HONORS
`2017
`
`American Academy of Dermatology – Presidential Citation for
`service in insurer and regulatory advocacy
`American Academy of Dermatology – Presidential Citation for
`service as advisor to AMA RUC
`American Academy of Dermatology – Performance Measures
`Pioneer Award
`Distinguished Service Award, American College of Mohs
`Surgery
`1999-2000 Chief Resident, Dermatology Residency, Washington
`University School of Medicine
`1996 Henry Yalem Prize in Dermatology, awarded for outstanding
`
`2017
`
`2017
`
`2014
`
`5
`
`
`
`work in Dermatology
`1995 Spencer T. Olin Fellowship in recognition of superior
`achievement in biomedical research
`1989-1995 Swazey Scholar for Academic Distinction in Medical Pursuits
`
`Languages – English, Spanish
`
`PUBLICATIONS
`1. Burd PR, Rogers HW, Gordon JR, Martin CA, Jayaraman S,
`Wilson S, Dvorak AM, Galli SJ, Dorf ME: Interleukin 3-
`dependent and independent mast cells stimulated with IgE
`and antigen express multiple cytokines. J Exp Med
`170:245-257, 1989.
`2. Rogers HW, Sheehan KCF, BruntLM, DowerSK, Unanue
`ER, Schreiber RD: Interleudin-1 participates in the
`development of anti-Listeria responses in normal and SCID
`mice. Proc Natl Acad Sci USA 89:1011-1015, 1992.
`3. Beckerman KP, Rogers HW, Corbett JA, Schreiber RD,
`McDaniel ML, Unanue ER: Release of nitric oxide during
`the T cell independent pathway of macrophage activation.
`Its roles in resistance to Listeria monocytogenes. J Immunol
`150: 888-895, 1993
`4. Rogers HW, Unanue ER: Neutrophils are involved in acute,
`nonspecific resistance to Listeria monocytogenes in mice.
`Infect and Immun 61:5090-5096, 1993.
`5. Rogers HW, Tripp CS, Schreiber RD, Unanue ER:
`Endogenous IL-1 is required for neutrophil recruitment and
`
`6
`
`
`
`macrophage activation during murine Listeriosis. J Immunol
`152:2093-2101, 1994.
`6. Rogers HW, Unanue ER: Different stages in the natural and
`acquired resistance to an intracellular pathogen. The
`Immunologist 3:152-156, 1995.
`7. Rogers HW, Callery M, Unanue ER: Listeria induces
`hepatocyte apoptosis: implications for the role of neutrophils
`in Listeria resistance. J Immunol 156:679-684, 1996.
`
`8. Coldiron BM, Dinehart S, Rogers HW: Sentinel lymph
`node biopsy and completion lymph node dissection for
`malignant melanoma are not standard of care. Clin.
`Dermatol. 2009.
`
`9. Rogers HW, Coldiron BM: A Relative Value Unit Based
`Cost Comparison of Treatment Modalities for Non-
`Melanoma Skin Cancer. J Am Acad Dermatol. 2009
`Jul;61(1):96-103.
`10.Rogers HW, Coldiron BM: Sentinel node biopsy not
` standard of care for melanoma. J Am Acad Dermatol. 2011
` Feb;64(2):441.
`11.Rogers HW, Coldiron BM: Unconflicted. J Am Acad
` Dermatol. 2011 Feb;64(2):437-8.
`12.Rogers HW, Weinstock MA, Harris AR, Hinckley MR,
` Feldman SR, Fleischer AB, Coldiron BM: Incidence
` estimate of nonmelanoma skin cancer in the United States,
` 2006. Arch Dermatol. 2010 Mar;146(3):283-7.
`13. Rogers HW, Coldiron BM. Analysis of skin cancer
` treatment and costs in the United States Medicare
`
`7
`
`
`
` population, 1996-2008. Dermatol Surg. 2013 Jan;39(1 Pt
` 1):35-42.
`14. Rogers HW, Coldiron BM, Dinehart SM, Hendi A, Hruza
` G, Fosko SW, Moody BR. Skin cancer treatment fee
` comparisons inaccurate. Dermatol Surg. 2012
` Dec;38(12):2038-9.
`15. Rogers HW, Weinstock MA, Feldman SR, Coldiron BM.
` Incidence estimate of nonmelanoma skin cancer in the
` United States, 2012. Arch Dermatol. JAMA Dermatol.
` 2015 Oct;151(10):1081-6.
`16. Rogers HW. Is cryosurgery cost effective in the treatment
` of non-melanoma skin cancer? Dermatological
` Cryosurgery and Cryotherapy, Springer, New York, NY.
` 2016.
`17. Rogers HW. Is Mohs Surgery Cost-Effective versus
` Traditional Surgical Excision? Current Dermatology
` Reports: Volume 3, Issue 2 (2014), 91-97.
`18. Leitenberger JJ, Rogers HW, Chapman JC, Maher IA, Fox
` MC, Harmon CB, Bailey EC, Wisco OJ. Defining
` Recurrence of Non-Melanoma Skin Cancer after Mohs
` Micrographic Surgery: Report of the American College of
` Mohs Surgery Registry and Outcomes Committee. J Am
` Acad Dermatol. 2016 Nov;75(5):1022-1031.
`19. Rogers HW. One diagnosis and modifier -25: appropriate
` or audit target? Cutis. 2017 Mar;99(3):165-166.
`20. Rogers HW. Phototherapy coding in the time of biologics.
` Cutis. 2017 July;100(1):41-42.
`
`8
`
`
`
`21. Tolkachjov SN, Brodland DG, Coldiron BM, Fazio MJ,
`
`Hruza GJ, Roenigk RK, Rogers HW, Zitelli JA, Winchester
`
`DS, Harmon CB. Understanding Mohs Micrographic Surgery:
`
`A Review and Practical Guide for the Nondermatologist. Mayo
`
`Clin Proc. 2017 Aug;92(8):1261-1271.
`
`22. Rogers HW. Modifier -25 Victory, But the Battle Is Not
`
`Over. Cutis. 2018 June;101(6):409-410
`
`23. Rogers HW. Practice Expense–Only Codes: No Physician
`
`Work, No Sweat. Cutis. 2018 Nov;101(6):348-352
`
`24. Rogers HW, Beveridge M, Puente J, Wixson S, Loy B,
`
`Happe LE Incidence of non-melanoma skin cancer in the US
`
`population aged 65 years and older, 2014. J Am Acad
`
`Dermatol. J Am Acad Dermatol. 2021 Sep;85(3):741-743.
`
`25. Aizman L , Damavandy AA , Snider CK , Lukowiak TM ,
`
`Perz AM , Etzkorn JM , Beer J , Thuzar M Shin , Sobanko JF ,
`
`Giordano CN , Higgins HW, Fischer J, Brody RM , Rogers
`
`HW , Miller CJ. Incidence of and risk factors for neighboring
`
`synchronous skin cancers during Mohs micrographic surgery: A
`
`prospective cohort study J Am Acad Dermatol. 2021 Apr
`
`20;S0190-9622.
`
`9
`
`
`
`26. Rogers HW. Modifier -25 and the New 2021 E/M Codes:
`
`Documentation of Separate and Distinct Just Got Easier Cutis.
`
`2021 Sept.;108(03):131-132, 162
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`10
`
`
Accessing this document will incur an additional charge of $.
After purchase, you can access this document again without charge.
Accept $ Charge
Still Working On It
This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.
Give it another minute or two to complete, and then try the refresh button.
A few More Minutes ... Still Working
It can take up to 5 minutes for us to download a document if the court servers are running slowly.
Thank you for your continued patience.
This document could not be displayed.
We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.
Your account does not support viewing this document.
You need a Paid Account to view this document. Click here to change your account type.
Your account does not support viewing this document.
Set your membership
status to view this document.
With a Docket Alarm membership, you'll
get a whole lot more, including:
- Up-to-date information for this case.
- Email alerts whenever there is an update.
- Full text search for other cases.
- Get email alerts whenever a new case matches your search.
One Moment Please
The filing “” is large (MB) and is being downloaded.
Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.
Your document is on its way!
If you do not receive the document in five minutes, contact support at support@docketalarm.com.
Sealed Document
We are unable to display this document, it may be under a court ordered seal.
If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.
Access Government Site
